D. Babikyan

发表

Classification of missense substitutions in the BRCA genes: A database dedicated to Ex‐UVs

F. Couch, S. Tavtigian, D. Goldgar, 2012, Human mutation.

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

C. Cotman, V. Vasilevko, D. Cribbs, 2003, International immunology.

Adjuvant-dependent modulation of T h 1 and T h 2 responses to immunization with b-amyloid

C. Cotman, V. Vasilevko, D. Cribbs, 2003 .

Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study

J. Hopper, E. John, M. Southey, 2011, Breast Cancer Research.

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Alun Thomas, Sue Healey, John L Hopper, 2009, American journal of human genetics.

Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.

Sue Healey, John L Hopper, Georgia Chenevix-Trench, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities.

R. Redon, J. Honnorat, A. Toutain, 2021, American journal of human genetics.

The utility of sufficiently informative protein multiple sequence alignment for cancer risk assessment OF BRCA2 missense substitutions

D. Babikyan, 2016 .

Generation and characterization of the humoral immune response to DNA immunization with a chimeric β‐amyloid‐interleukin‐4 minigene

E. Head, V. Vasilevko, D. Cribbs, 2003, European journal of immunology.

Comprehensive analysis of mutations in the MEFV gene reveal that the location and not the substitution type determines symptom severity in FMF

T. Sarkisian, H. Hayrapetyan, M. Moradian, 2017, Molecular genetics & genomic medicine.

Overview of Cancer Control in Armenia and Policy Implications

A. Avagyan, L. Sargsyan, T. Sarkisian, 2022, Frontiers in Oncology.

A novel variant of C12orf4 in a consanguineous Armenian family confirms the etiology of autosomal recessive intellectual disability type 66 with delineation of the phenotype

Z. Sedlacek, V. Stránecký, M. Hancarova, 2019, Molecular genetics & genomic medicine.

Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer

T. Sarkisian, M. Moradian, Nare Avanesian, 2021, Human genome variation.